Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate Gel and BMP-2 Gel for Dental Implant Stability
NCT04140006Phase 2Unknown
- Sponsor
- University of Baghdad
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of alendronate and dibotermin alfa in partial edentulism (4 arms), sponsored by University of Baghdad. Primary endpoints: Implant stability and Crestal bone level. Status: unknown.
02
Drugs
alendronatedibotermin alfa
03
Conditions
partial edentulism
Beyond the preview
Go deeper on NCT04140006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140006.